Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Aleniglipron

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Gasherbrum Bio, Inc · Phase 3 · Recruiting · Enrollment 3600

NCT07654361

ArmPopulationDoseWeeksEstimandWeight change
aleniglipron Arm 1Obesity or overweightn/r76n/rn/r
aleniglipron Arm 2Obesity or overweightn/r76n/rn/r
aleniglipron Arm 3Obesity or overweightn/r76n/rn/r
Placebo Arm 4Obesity or overweightn/r76n/rn/r